Artificial Intelligence in Medicine
Objective
Partnering & Commercialization of AIM – Artificial Intelligence in Medicine program from Cedars Sinai. Cedars is seeking a distribution partnership to license AIM in Asia
Target markets
- China
- India
- Israel
- Korea
- Japan
Technology
AIM is a software suite that allows for processing and analysis of 3D images of the heart leading to measurements that help cardiologists the state & behavior of the heart.
- Reconstruction & Reorientation
- Perfusion & Function Quantification
- Automated Reporting
AIM algorithms have been developed to:
- Take raw digital data output from CT/PET/SPECT/GAMMA camera among others
- Take tomographic images of the heart
- Analyze the dynamic functioning of the heart
- Be compatible across imaging devices (GE, Siemens, Phillips etc) in nuclear medicine/cardiology facilities
AIM Features
- QGS+QPS – Quantitative Gated + Perfusion SPECT
- QBS – Quantitative Blood Pool SPECT
- QPET – Quantitative PET
- ARG – Automated Report Generator
- AutoRecon
- MoCo – Motion Correction
Partnering Advantages
- Engage over read-to-deploy, validated platform – considered the gold standard in nuclear cardiology
- Globally recognized software & algorithm with high acceptance in the medical community
- Increasing consumer base with new nuclear medicine/cardiology centres each year
For partnering and additional information, please write to nikhil.dhar@skyquestt.com